Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 334,185,184
  • Shares Outstanding, K 2,112,422
  • Annual Sales, $ 56,674 M
  • Annual Income, $ 13,984 M
  • EBIT $ 17,644 M
  • EBITDA $ 22,919 M
  • 60-Month Beta 0.50
  • Price/Sales 6.08
  • Price/Cash Flow 14.62
  • Price/Book 7.13

Options Overview Details

View History
  • Implied Volatility 23.62% (-0.88%)
  • Historical Volatility 20.42%
  • IV Percentile 81%
  • IV Rank 23.50%
  • IV High 43.36% on 04/08/25
  • IV Low 17.55% on 11/06/25
  • Expected Move (DTE 8) 3.43 (2.14%)
  • Put/Call Vol Ratio 1.54
  • Today's Volume 1,004
  • Volume Avg (30-Day) 2,433
  • Put/Call OI Ratio 1.72
  • Today's Open Interest 71,869
  • Open Int (30-Day) 59,318
  • Expected Range 156.63 to 163.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.17
  • Number of Estimates 3
  • High Estimate 2.26
  • Low Estimate 1.99
  • Prior Year 2.28
  • Growth Rate Est. (year over year) -4.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
140.30 +14.08%
on 01/12/26
160.18 -0.07%
on 02/11/26
+18.52 (+13.08%)
since 01/09/26
3-Month
123.24 +29.88%
on 11/20/25
160.18 -0.07%
on 02/11/26
+29.56 (+22.65%)
since 11/11/25
52-Week
97.71 +63.80%
on 04/09/25
160.18 -0.07%
on 02/11/26
+52.31 (+48.55%)
since 02/11/25

Most Recent Stories

More News
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?

Novartis (NVS) is trading at new all-time highs on Monday. Shares are up nearly 50% over the past 52 weeks. NVS maintains a 100% “Buy” technical opinion from Barchart. Novartis has benefitted in recent...

NVS : 160.06 (+1.18%)
Looking to ‘Sell America’ Amid Fed Drama? Here’s 1 ETF to Buy.

'Sell America' fear is rising again, and this non-U.S. ETF could be a wise buy to stay diversified and invested globally while U.S. policy risks swirl.

BLK : 1,082.88 (-0.45%)
BABA : 164.32 (-1.32%)
DXY00 : 96.846 (+0.01%)
SIH26 : 83.395 (-0.63%)
GCG26 : 5,060.4 (-0.22%)
NVS : 160.06 (+1.18%)
RHHBY : 57.7900 (+1.69%)
HSBC : 89.42 (-0.08%)
TSM : 374.09 (+3.37%)
ASML : 1,435.63 (+1.56%)
$DXY : 96.85 (+0.02%)
AZN : 204.76 (+5.87%)
Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

Salesforce (NYSE: CRM) , the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS) , a leading global innovative medicines company, has selected Salesforce’s...

NVS : 160.06 (+1.18%)
CRM : 185.00 (-4.37%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) on Monday rose by +1.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +1.82%. December E-mini S&P...

MSTR : 126.07 (-5.21%)
CADE : 42.11 (-1.66%)
AAPL : 275.50 (+0.67%)
RNA : 72.92 (+0.04%)
HBAN : 17.93 (-3.45%)
NVS : 160.06 (+1.18%)
$IUXX : 25,201.26 (+0.29%)
COIN : 153.20 (-5.73%)
ZNH26 : 112-100 (+0.03%)
TSLA : 428.27 (+0.72%)
ESH26 : 6,979.00 (+0.27%)
QCOM : 141.04 (+0.68%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. December E-mini S&P futures (ESZ25 )...

CADE : 42.11 (-1.66%)
RNA : 72.92 (+0.04%)
HBAN : 17.93 (-3.45%)
NVS : 160.06 (+1.18%)
$IUXX : 25,201.26 (+0.29%)
COIN : 153.20 (-5.73%)
ZNH26 : 112-100 (+0.03%)
TSLA : 428.27 (+0.72%)
ESH26 : 6,979.00 (+0.27%)
QCOM : 141.04 (+0.68%)
AWK : 123.69 (-1.07%)
KDP : 29.89 (+4.11%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.32%. December E-mini S&P futures (ESZ25 )...

MSTR : 126.07 (-5.21%)
CADE : 42.11 (-1.66%)
RNA : 72.92 (+0.04%)
HBAN : 17.93 (-3.45%)
NVS : 160.06 (+1.18%)
$IUXX : 25,201.26 (+0.29%)
COIN : 153.20 (-5.73%)
ZNH26 : 112-100 (+0.03%)
TSLA : 428.27 (+0.72%)
ESH26 : 6,979.00 (+0.27%)
KDP : 29.89 (+4.11%)
^ETCUSD : 8.27374 (+0.10%)
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END

BCAX : 14.80 (-1.14%)
OTLC : 0.0450 (-28.57%)
IOBT : 0.3555 (-3.16%)
NVS : 160.06 (+1.18%)
PFE : 27.73 (+0.43%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 311.33 (-2.29%)
META : 668.69 (-0.30%)
AAPL : 275.50 (+0.67%)
CVX : 185.82 (+1.95%)
WELL : 207.88 (+3.51%)
NVS : 160.06 (+1.18%)
ABBV : 220.89 (-0.70%)
UNH : 278.91 (+2.08%)
MSFT : 404.37 (-2.15%)
WM : 234.66 (+1.27%)
V : 329.24 (+0.33%)
XOM : 155.56 (+2.62%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 311.33 (-2.29%)
META : 668.69 (-0.30%)
AAPL : 275.50 (+0.67%)
CVX : 185.82 (+1.95%)
WELL : 207.88 (+3.51%)
NVS : 160.06 (+1.18%)
ABBV : 220.89 (-0.70%)
UNH : 278.91 (+2.08%)
MSFT : 404.37 (-2.15%)
WM : 234.66 (+1.27%)
V : 329.24 (+0.33%)
XOM : 155.56 (+2.62%)
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novartis AG, with a price target of CHF95.00. The company’s shares opened today at CHF106.36.Elevate Your Investing Strategy:...

NVS : 160.06 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 162.95
2nd Resistance Point 161.56
1st Resistance Point 160.81
Last Price 160.06
1st Support Level 158.67
2nd Support Level 157.29
3rd Support Level 156.54

See More

52-Week High 160.18
Last Price 160.06
Fibonacci 61.8% 136.32
Fibonacci 50% 128.95
Fibonacci 38.2% 121.58
52-Week Low 97.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar